Back to Search
HERNANDO D. CARTER MD
MD
Internal Medicine Physician
NPI: 1265604227Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
28511(AL)
Research & Publications (20)
Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations.
PMID 19654296·Cancer Res·2009
4-observational
Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience.
PMID 17936806·J Urol·2007
8-other
Prostate-specific antigen velocity risk count assessment: a new concept for detection of life-threatening prostate cancer during window of curability.
PMID 17991538·Urology·2007
8-other
Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability.
PMID 17077354·J Natl Cancer Inst·2006
4-observational
Can a baseline prostate specific antigen level identify men who will have lower urinary tract symptoms later in life?
PMID 15879821·J Urol·2005
8-other
Impact of a hospital palliative care service: perspective of the hospital staff.
PMID 12418366·J Palliat Care·2002
8-other
Expectant management of nonpalpable prostate cancer with curative intent: preliminary results.
PMID 11832703·J Urol·2002
8-other
Prevalence of hepatitis B and C infection in a methadone clinic population: implications for hepatitis B vaccination.
PMID 11548096·N Z Med J·2001
8-other
DNA content in the diagnostic biopsy for benign-adjacent and cancer-tissue areas predicts the need for treatment in men with T1c prostate cancer undergoing surveillance in an expectant management programme.
PMID 19678815·BJU Int·2010
8-other
CARP2 deficiency does not alter induction of NF-kappaB by TNFalpha.
PMID 19138581·Curr Biol·2009
7-preclinical
Disruption of orbitofrontal cortex laterality in offspring from multiplex alcohol dependence families.
PMID 18986649·Biol Psychiatry·2009
8-other
Discovery of an inhibitor of insulin-like growth factor 1 receptor activation: implications for cellular potency and selectivity over insulin receptor.
PMID 19665448·Biochem Pharmacol·2009
7-preclinical
Words of wisdom. Re: Long-term prediction of prostate cancer: prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population.
PMID 19606535·Eur Urol·2009
8-other
Attenuation of amphetamine-induced activity by the non-selective muscarinic receptor agonist, xanomeline, is absent in muscarinic M4 receptor knockout mice and attenuated in muscarinic M1 receptor knockout mice.
PMID 19111716·Eur J Pharmacol·2009
7-preclinical
Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes: 1. Identification of 1-amino-1-cycloalkyl carboxylic acid headgroups.
PMID 19095442·Bioorg Med Chem Lett·2009
7-preclinical
MODBASE, a database of annotated comparative protein structure models and associated resources.
PMID 18948282·Nucleic Acids Res·2009
8-other
Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy.
PMID 19138846·Bioorg Med Chem Lett·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 165 BESSEMER SUPER HWY
MIDFIELD, AL 35228 - Phone
- (205) 366-1534
Quick Facts
- NPI
- 1265604227
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile